Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Articles published by Medriva and BioSpace referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications,” examined the clinical development landscape and potential impacts of the Inflation Reduction Act (IRA) of 2022 on high-spend Medicare Part D small molecule drugs, finding that longer development timelines and decreased investments in additional indications could reduce incentives for postapproval research.
An article from Myasthenia Gravis News referenced an article published on AJMC.com, the website of AJMC. The article, “Not So Rare: 300 Million People Worldwide Affected by Rare Diseases,” summarized a study that estimated that approximately 4% of the total world population is affected by a rare disease.
Articles from Medpage Today and Drug Topics® referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “FDA Approves First Denosumab Biosimilars,” reported on the FDA approvals for Sandoz’ Wyost and Jubbonti (both denosumab-bddz) to treat osteoporosis and prevent skeletal-related events associated with bone metastases from solid tumors. The biosimilars are the first approved products to reference originator denosumab (Prolia/Xgeva).
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More